RMD Financials: Results, Ratios & Statements | Resmed

RMD

Resmed

Health Care Equipment & Services

ResMed is a global leader in the design, manufacture, and distribution of medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders, including sleep apnea, COPD, and other chronic diseases. The company's core business revolves around providing innovative solutions for improving the quality of life for people with respiratory conditions, holding a significant market share in the sleep apnea treatment market.

Short position

short percentage0.44%

reported shorts2.5M

shares on issue570.128M

Resmed (ASX:RMD) has 0.44% of its shares on issue reported as short positions as of 5 Oct 2026, or about 2,484,851 shares. Over the past 30 days that figure has fallen 0.12 percentage points, and over 90 days it has risen 0.08 percentage points. Its highest recorded short interest was 3.10% in October 2014. RMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in USD, the reporting currency

Revenue: 5.65Bvs 5.15B (FY25); Yahoo Finance, as at 29 Sep 2026
NPAT: 1.52Bvs 1.40B (FY25); Yahoo Finance, as at 29 Sep 2026
EPS (diluted): 1.04vs 0.95 (FY25); Yahoo Finance, as at 29 Sep 2026

Rev YoY: +9.9%FY
EPS YoY: +9.7%TTM

Key ratios

Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026

Gross margin: 61.1%
Operating margin: 33.8%
Net margin: 26.9%
FCF margin: 28.8%
ROE: 24.3%
ROA: 17.8%
FCF conversion: 1.07×
Net cash (excl. leases): USD 809.9M
Net debt / EBITDA: −0.4×
Current ratio: 3.1×
Interest cover: n/a
Cash dividends paid / net profit: 23.0%
Market cap: n/a (listed unit is not one ordinary share)
P/E: n/a (listed unit is not one ordinary share)
P/B: n/a (listed unit is not one ordinary share)

Ratios use the reporting currency (USD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.

Financial statements

Figures in USD, the reporting currency; Yahoo Finance unless marked

RMD income, newest period first, figures in USD
Line item	FY26	FY25	FY24	FY23
Revenue	5.65B	5.15B	4.69B	4.22B
Gross profit	3.45B	3.05B	2.66B	2.36B
Operating income	1.91B	1.69B	1.38B	1.15B
EBITDA	2.15B	1.92B	1.60B	1.35B
EBIT	1.91B	1.69B	1.38B	1.15B
Interest expense	n/a	n/a	45.7M	47.4M
Pretax income	1.92B	1.68B	1.26B	1.10B
Tax	396.1M	276.8M	243.8M	204.1M
NPAT	1.52B	1.40B	1.02B	897.6M
Net interest income	49.9M	4.1M	−45.7M	−47.4M
EPS basic	1.05	0.95	0.69	0.61
EPS diluted	1.04	0.95	0.69	0.61
Shares	144.2M	146.4M	146.9M	147.1M

Financial reports

The company's own filings, newest first